Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00930_DB01586_nanopub.RA3T5KeAPZp9JG-2GpEOKFk0ARA-RizmWJ-kcX9R9g3yQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00930_DB01586 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00930_DB01586 label "DDI between Colesevelam and Ursodeoxycholic acid - Bile Acid Sequestrants may decrease the serum concentration of Ursodiol. Consider administration of ursodiol 5 hours or more after bile acid sequestrants to minimize ursodiol adsorption in the gastrointestinal tract. Monitor for decreased therapeutic effects of ursodiol in patients receiving bile acid sequestrants. [drugbank_resource:DB00930_DB01586]" assertion.
- drugbank_resource:DB00930_DB01586 identifier "drugbank_resource:DB00930_DB01586" assertion.
- drugbank_resource:DB00930_DB01586 title "DDI between Colesevelam and Ursodeoxycholic acid - Bile Acid Sequestrants may decrease the serum concentration of Ursodiol. Consider administration of ursodiol 5 hours or more after bile acid sequestrants to minimize ursodiol adsorption in the gastrointestinal tract. Monitor for decreased therapeutic effects of ursodiol in patients receiving bile acid sequestrants." assertion.
- drugbank:DB01586 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00930_DB01586 assertion.
- drugbank:DB00930 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00930_DB01586 assertion.